These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 23855289)

  • 21. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral hepatitis in Nigeria--sickle-cell disease and commercial blood donors.
    Mutimer DJ; Olomu A; Skidmore S; Olomu N; Ratcliffe D; Rodgers B; Mutimer HP; Gunson BK; Elias E
    QJM; 1994 Jul; 87(7):407-11. PubMed ID: 7922292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population.
    Chen F; Zhang J; Guo F; Wen B; Luo S; Yuan D; Lin Y; Ou W; Tang P; Dai G; Li F; Liu W; Qu X
    J Gastroenterol Hepatol; 2017 Feb; 32(2):515-520. PubMed ID: 27248508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
    Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing.
    Murokawa H; Yoshikawa A; Ohnuma H; Iwata A; Katoh N; Miyamoto M; Mine H; Emura H; Tadokoro K;
    Vox Sang; 2005 Jan; 88(1):10-6. PubMed ID: 15663717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization.
    Wen WH; Chen HL; Ni YH; Hsu HY; Kao JH; Hu FC; Chang MH
    Hepatology; 2011 Feb; 53(2):429-36. PubMed ID: 21274864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey.
    Sakarya S; Oncu S; Ozturk B; Oncu S
    Saudi Med J; 2004 Aug; 25(8):1070-2. PubMed ID: 15322600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimization of hepatitis B infection by a 25-year universal vaccination program.
    Ni YH; Chang MH; Wu JF; Hsu HY; Chen HL; Chen DS
    J Hepatol; 2012 Oct; 57(4):730-5. PubMed ID: 22668640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
    Rouet F; Chaix ML; Inwoley A; Msellati P; Viho I; Combe P; Leroy V; Dabis F; Rouzioux C;
    J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological update of hepatitis B, C and delta in Latin America.
    Alvarado-Mora MV; Pinho JR
    Antivir Ther; 2013; 18(3 Pt B):429-33. PubMed ID: 23792375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of HBV and HCV infections, Bhutan, 2017: Progress and next steps.
    Tshering N; Dhakal GP; Wangchuk U; Wangdi S; Khandu L; Pelden S; Nogareda F; Patel MK; Hutin YJF; Wannemuehler K; Rewari BB; Wangchuk S
    BMC Infect Dis; 2020 Jul; 20(1):485. PubMed ID: 32641006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
    Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
    Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B and C virus infection among hemodialysis patients in Yogyakarta, Indonesia: Prevalence and molecular evidence for nosocomial transmission.
    Rinonce HT; Yano Y; Utsumi T; Heriyanto DS; Anggorowati N; Widasari DI; Lusida MI; Soetjipto ; Prasanto H; Hotta H; Hayashi Y
    J Med Virol; 2013 Aug; 85(8):1348-61. PubMed ID: 23919229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia.
    Almawi WY; Qadi AA; Tamim H; Ameen G; Bu-Ali A; Arrayid S; Abou Jaoude MM
    Transplant Proc; 2004; 36(6):1824-6. PubMed ID: 15350487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple genotypes and subtypes of hepatitis B and C viruses in Belarus: similarities with Russia and western European influences.
    Olinger CM; Lazouskaya NV; Eremin VF; Muller CP
    Clin Microbiol Infect; 2008 Jun; 14(6):575-81. PubMed ID: 18373690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization.
    Tsatsralt-Od B; Takahashi M; Endo K; Agiimaa D; Buyankhuu O; Ninomiya M; Lorenzo FR; Okamoto H
    J Med Virol; 2007 Aug; 79(8):1064-74. PubMed ID: 17596839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for hepatitis B and C infection among blood donors in five Chinese blood centers.
    Huang Y; Guo N; Yu Q; Lv Y; Ma H; Yun Z; Yao F; Dong X; Zhu X; Wen X; Cao R; Huang M; Bi X; Zhao M; Tiemuer MH; Li J; Zhou Z; He W; Liu J; Wright DJ; Wang J; Ness P; Shan H;
    Transfusion; 2015 Feb; 55(2):388-94. PubMed ID: 25382751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological study of hepatitis B and hepatitis C infections in Northeastern China and the beneficial effect of the vaccination strategy for hepatitis B: a cross-sectional study.
    Wang S; Tao Y; Tao Y; Jiang J; Yan L; Wang C; Ding Y; Yu J; Zhao D; Chi X; Wang X; Wu R; Gao X; Shi Y; Guan Y; Li Y; Xing Y; Sun H; Ta C; Wang C; Niu J; Meng J; Xu H
    BMC Public Health; 2018 Sep; 18(1):1088. PubMed ID: 30176842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.